【レポートの概要（一部）】
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Emerging Markets
3.7 Futuristic Market Scenario
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Breast Cancer Drug Market, By Type
5.1 Introduction
5.2 Mitotic Inhibitor
5.3 Aromatase Inhibitor
5.4 Hormonal rec
5.5 HER2 Inhibitor
5.6 Anti-Metabolites
5.7 CDK 4/6 Inhibitor
6 Global Breast Cancer Drug Market, By Drug
6.1 Introduction
6.2 Targeted Therapy Drugs
6.2.1 Ado-Trastuzumab Emtansine
6.2.2 Neratinib
6.2.3 Monoclonal Antibodies (mAbs)
6.2.3.1 Bevacizumab
6.2.3.2 Trastuzumab
6.2.3.3 Other Monoclonal Antibodies (mAbs)
6.2.4 Lapatinib
6.2.5 Tyrosine kinase inhibitors
6.3 Chemotherapy Drugs
6.3.1 Antimetabolites
6.3.1.1 Capecitabine
6.3.1.2 Gemcitabine
6.3.1.3 Fluorouracil
6.3.2 Anthracyclines
6.3.2.1 Epirubicin
6.3.2.2 Doxorubicin
6.3.3 Alkylating Agents
6.3.4 Neoadjuvant Chemotherapy
6.3.5 Adjuvant Chemotherapy
6.3.6 Taxanes
6.3.6.1 Docetaxel
6.3.6.2 Paclitaxel
6.3.7 Advanced Breast Cancer
6.3.8 Epothilones
6.4 Hormone Therapy Drugs
6.4.1 Ecstasy and Related Drug (ERD)
6.4.2 Selective Estrogen-Receptor Modulators (SERMs)
6.4.2.1 Tamoxifen
6.4.2.2 Toremifene
6.4.2.3 Raloxifene
6.4.3 Aromatase Inhibitors
6.4.3.1 Anastrozole
6.4.3.2 Letrozole
6.4.3.3 Megestrol
6.4.5 Luteinising Hormone-Releasing Hormone
6.4.6 Other Hormonal Therapies
6.4.6.1 Goserelin Acetate
6.4.6.2 Fulvestrant
6.4.6.3 Fluoxymesterone
6.5 Other Drugs
7 Global Breast Cancer Drug Market, By Distribution Channel
7.1 Introduction
7.2 Clinics
7.3 Online Pharmacies
7.4 Ambulatory Surgical Centers
7.5 Hospitals
7.6 Retail Pharmacies
8 Global Breast Cancer Drug Market, By Drug
8.1 North America
8.1.1 US
8.1.2 Canada
8.1.3 Mexico
8.2 Europe
8.2.1 Germany
8.2.2 France
8.2.3 Italy
8.2.4 UK
8.2.5 Spain
8.3 Asia Pacific
8.3.1 Japan
8.3.2 China
8.3.3 India
8.3.4 Australia
8.3.5 New Zealand
8.3.6 Rest of Asia Pacific
8.4 South America
8.4.1 Argentina
8.4.2 Brazil
8.4.3 Venezuela
8.4.4 Chile
8.4.5 Peru
8.5 Middle East & Africa
8.5.1 UAE
8.5.2 Saudi Arabia
8.5.3 Qatar
8.5.4 Iran
8.5.5 South Africa
8.5.6 Rest of MEA
9 Vendor Landscaping
9.1 Agreements, Partnerships, Collaborations and Joint Ventures
9.2 Acquisitions & Mergers
9.3 New Product Launch
9.4 Expansions
9.5 Other Key Strategies
10 Company Profiles
10.1 Novartis AG
10.2 Celgene Corporation
10.3 Janssen Global Services LLC
10.4 Onyx Pharmaceuticals Inc.
10.5 AbbVie, Inc.
10.6 Eli Lilly and Company
10.7 Celldex Therapeutics
10.8 BioNumerik Pharmaceuticals, Inc.
10.9 AstraZeneca
10.10 Merck & Co., Inc.
10.11 Genzyme Corporation
10.12 MacroGenics, Inc.
10.13 F. Hoffmann-La Roche Ltd.
10.14 Biocon
List of Tables
Table 1 Global Breast Cancer Drug Market Outlook, By Region (2016-2026)(US $MN)
Table 2 Global Breast Cancer Drug Market Outlook, By Type (2016-2026)(US $MN)
Table 3 Global Breast Cancer Drug Market Outlook, By Mitotic Inhibitor (2016-2026)(US $MN)
Table 4 Global Breast Cancer Drug Market Outlook, By Aromatase Inhibitor (2016-2026)(US $MN)
Table 5 Global Breast Cancer Drug Market Outlook, By Hormonal rec (2016-2026)(US $MN)
Table 6 Global Breast Cancer Drug Market Outlook, By HER2 Inhibitor (2016-2026)(US $MN)
Table 7 Global Breast Cancer Drug Market Outlook, By Anti-Metabolites (2016-2026)(US $MN)
Table 8 Global Breast Cancer Drug Market Outlook, By CDK 4/6 Inhibitor (2016-2026)(US $MN)
Table 9 Global Breast Cancer Drug Market Outlook, By Drug (2016-2026)(US $MN)
Table 10 Global Breast Cancer Drug Market Outlook, By Targeted Therapy Drugs (2016-2026)(US $MN)
Table 11 Global Breast Cancer Drug Market Outlook, By Ado-Trastuzumab Emtansine (2016-2026)(US $MN)
Table 12 Global Breast Cancer Drug Market Outlook, By Neratinib (2016-2026)(US $MN)
Table 13 Global Breast Cancer Drug Market Outlook, By Monoclonal Antibodies (mAbs) (2016-2026)(US $MN)
Table 14 Global Breast Cancer Drug Market Outlook, By Lapatinib (2016-2026)(US $MN)
Table 15 Global Breast Cancer Drug Market Outlook, By Tyrosine kinase inhibitors (2016-2026)(US $MN)
Table 16 Global Breast Cancer Drug Market Outlook, By Chemotherapy Drugs (2016-2026)(US $MN)
Table 17 Global Breast Cancer Drug Market Outlook, By Antimetabolites (2016-2026)(US $MN)
Table 18 Global Breast Cancer Drug Market Outlook, By Anthracyclines (2016-2026)(US $MN)
Table 19 Global Breast Cancer Drug Market Outlook, By Alkylating Agents (2016-2026)(US $MN)
Table 20 Global Breast Cancer Drug Market Outlook, By Neoadjuvant Chemotherapy (2016-2026)(US $MN)
Table 21 Global Breast Cancer Drug Market Outlook, By Adjuvant Chemotherapy (2016-2026)(US $MN)
Table 22 Global Breast Cancer Drug Market Outlook, By Taxanes (2016-2026)(US $MN)
Table 23 Global Breast Cancer Drug Market Outlook, By Advanced Breast Cancer (2016-2026)(US $MN)
Table 24 Global Breast Cancer Drug Market Outlook, By Epothilones (2016-2026)(US $MN)
Table 25 Global Breast Cancer Drug Market Outlook, By Hormone Therapy Drugs (2016-2026)(US $MN)
Table 26 Global Breast Cancer Drug Market Outlook, By Ecstasy and Related Drug (ERD) (2016-2026)(US $MN)
Table 27 Global Breast Cancer Drug Market Outlook, By Selective Estrogen-Receptor Modulators (SERMs) (2016-2026)(US $MN)
Table 28 Global Breast Cancer Drug Market Outlook, By Aromatase Inhibitors (2016-2026)(US $MN)
Table 29 Global Breast Cancer Drug Market Outlook, By Luteinising Hormone-Releasing Hormone (2016-2026)(US $MN)
Table 30 Global Breast Cancer Drug Market Outlook, By Other Hormonal Therapies (2016-2026)(US $MN)
Table 31 Global Breast Cancer Drug Market Outlook, By Distribution Channel (2016-2026)(US $MN)
Table 32 Global Breast Cancer Drug Market Outlook, By Clinics (2016-2026)(US $MN)
Table 33 Global Breast Cancer Drug Market Outlook, By Online Pharmacies (2016-2026)(US $MN)
Table 34 Global Breast Cancer Drug Market Outlook, By Ambulatory Surgical Centers (2016-2026)(US $MN)
Table 35 Global Breast Cancer Drug Market Outlook, By Hospitals (2016-2026)(US $MN)
Table 36 Global Breast Cancer Drug Market Outlook, By Retail Pharmacies (2016-2026)(US $MN)
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.
【レポート販売概要】
■ タイトル：乳がん薬の世界市場展望2017-20276■ 英文：Breast Cancer Drug - Global Market Outlook (2017-2026)
■ 発行日：2019年7月
■ 調査会社：Stratistics MRC
■ 商品コード：SMRC20FB349
■ 調査対象地域：グローバル
- Acciona Energia, S.A.：発電所及びSWOT分析2013Acciona Energia, S.A. - Power Plants and SWOT Analysis, 2013 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (executives), and major products and services. Scope - Major Power Plants (assets) - summarized a …
- Qsymia（肥満治療薬）：市場予測及び分析（～2022）Qsymia (Obesity) - Forecast and Market Analysis to 2022 Summary After a more than decade-long dormancy, the obesity market is undergoing a revival with the advent of several novel therapies that will lend considerable visibility to this indication space. This includes the use of combination therapies that simultaneously target multiple pathways and regulate appetite control, as well as novel molec …
- 再生可能エネルギー政策分析：January 2014Renewable Policy Analysis - January 2014 Summary GlobalData’s latest renewable policy report covers major policy developments in the renewable energy market for December 2013. The report consists of - • Featured articles: analytical articles related to the impact of major policies in the renewable energy market • Key news highlights: key renewable policy news alerts • Major policy updates: regiona …
- Taiwan Power Company, Ltd.：発電所及びSWOT分析2013Taiwan Power Company, Ltd. - Power Plants and SWOT Analysis, 2013 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (executives), and major products and services. Scope - Major Power Plants (assets) - summari …
- ハイコンテンツスクリーニング（HCS）の世界市場About HCS High-content screening (HCS) technology involves imaging-based multi-parametric analysis at the single-cell level. This technology was initially developed to complement biological high throughput screening in drug discovery. HCS analyses phenotypic changes in cellular samples. Technavio's analysts forecast the global HCS market to grow at a CAGR of 11.53% over the period 2014-2019. [Cove …
- スマートカードICの世界市場2019-2023Global Smart Card IC Market: About this market Technavio’s smart card IC market analysis considers sales from 16-bit and 32-bit microprocessor architecture. Our analysis also considers the sales of smart card IC in APAC, Europe, North America, South America, and MEA. In 2018, the 16-bit segment had a significant market share, and this trend is expected to continue over the forecast period. Factors …
- Black Hills Corporation：石油・ガスバリューチェーン分析レポート2013Black Hills Corporation Analysis Across the Oil and Gas Value Chain Report, 2013 Update Summary "Black Hills Corporation" Analysis Across the Oil and Gas Value Chain is an essential source for data, analysis and strategic insight into “Black Hills Corporation”. The report provides key information relating to oil and gas assets of the company along with its operations across the value chain. The re …
- 携帯電話用ケース及び機構部品製造の世界市場2015-2019About Mobile Phone Cases and Structural Parts Mobile phone cases and structural parts are the essential components of a mobile phone. Mobile phone manufacturers attach a high significance to the casing, as it forms an important factor for product differentiation and unique selling point. Consumers over the years have been looking at personalizing their mobile phones through different phone cases. …
- City Utilities of Springfield：発電所及びSWOT分析2013City Utilities of Springfield - Power Plants and SWOT Analysis, 2013 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (executives), and major products and services. Scope - Major Power Plants (assets) - summ …
- プロテアーゼの世界市場：微生物由来、動物由来、植物由来、レニン、パパイン、アルカリ性、酸性、中性プロテアーゼThe market for proteases is projected to reach ~USD 2.21 Billion by 2021, at a CAGR of 6% from 2016 to 2021. The proteases market is fueled by growing industrialization, increasing incidence of diseases, growing environmental concern, and focus on cost reduction and resource optimization, which has led to a large-scale adoption of proteases for various applications. The proteases market is segment …
- ジストニア(Dystonia)：世界の治験レビュー（2015年上半期版）Dystonia Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Dystonia Global Clinical Trials Review, H1, 2015" provides data on the Dystonia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Dystonia. It includes an overview of the trial numbers and their recruitment status as per the site of trial condu …
- 織物試験/検査/認証（TIC）の世界市場Testing, inspection, and certification (TIC) companies are providing services to textile manufacturers, which ensure that their textile products meet various quality standards and regulations. Standards such as ISO/TC 38/SC 1 and ISO/TC 38/SC 20 are used in textile testing to ensure the quality of textiles. Textile testing includes chemical testing, color fastness, physical test parameters, and ot …
- IT家電のグローバルトレンド及び予測2011-2018（Computing Electronics – Global Trends, Estimates and Forecasts, 2011-2018）Global Market Watch: With a CAGR of 10 %, global market value for computing electronics application sector is anticipated to be worth US$436.7 billion by 2018. On a global scale, Asia-Pacific accounts for more than 35% of the market share. While US accounts for the largest share of the global market value on a country basis, India and China surpasses the US in terms of growth rate anticipated in t …
- グローバル戦場管理システム市場予測及び分析（2014 – 2019）※当レポートは世界の戦場管理システム（BMS）における地域別・プラットフォーム別動向、応用分野シナリオ、課題、プログラム導入状況、市場機会、商品ライフサイクルなどをまとめました。 The report provides an in-depth analysis of the global BMS market. It provides information about the current trends in the market with respect to geographies, countries, platforms, and, applications market scenario. It throws light on the current market trends, the drivers, and restraints of this market, and …
- 電子医療記録（EHR）の世界市場分析：製品別（クライアントサーバーベース、Webベース）、タイプ別（急性、外来性、急性後）、エンドユーザー別（病院、外来診療）、セグメント予測、2014-2025The global Electronic Health Records (EHR) market is expected to reach USD 33.41 billion by 2025, according to a new report by Grand View Research, Inc. The government initiatives undertaken in support of EHR adoption are most likely to accentuate the market growth. The federal government introduced Health Information Technology for Economic and Clinical Health (HITECH) Act in 2009 for promoting u …
